Guntersville, ALNCT05535946Now EnrollingIRB Ready

I cannot determine the primary medical condition from the provided information. The study title "ABTECT - Maintenance" and the conditions listed only mention the drug ABX464 and placebo, without specifying what medical condition is being treated. The brief summary section appears to contain only a localhost URL rather than actual clinical information. Clinical Trial in Guntersville, AL

Access cutting-edge i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. treatment through this clinical trial at a research site in Guntersville. Study-provided care at no cost to qualified participants.

Sponsored by Abivax S.A.

Quick Self-Assessment

See if you qualify for this Guntersville location

Preparing your pre-screening questions...

Expert Care in Guntersville

Access i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. treatment provided free

Apply for This Guntersville Location

Check if you qualify for this i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. clinical trial in Guntersville, AL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Guntersville

    Convenient for AL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Guntersville site if eligible
  4. 4Begin participation

About This I cannot determine the primary medical condition from the provided information. The study title "ABTECT - Maintenance" and the conditions listed only mention the drug ABX464 and placebo, without specifying what medical condition is being treated. The brief summary section appears to contain only a localhost URL rather than actual clinical information. Study in Guntersville

This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhi

Sponsor: Abivax S.A.

Who Can Participate

Inclusion Criteria

in maintenance phase:
Subjects must have completed the induction treatment study (ABX464-105 or ABX464-106), and patients' clinical response status must be available.
Subjects with a valid endoscopy performed at the end of the induction study and results from central reader available at Day 1.
Subjects must understand, sign and date the written voluntary informed consent form at the visit prior to any protocol-specific procedures. For under-aged subjects, national requirements regarding consent should also be met.
Women of childbearing potential (WOCBP) subjects and male subjects with WOCBP partner must agree to comply with contraception requirements as described in Section 4.4. (Contraception) of the protocol.
Subjects must be able and willing to comply with study visits and procedures as per protocol.
Subjects should be affiliated to a health insurance policy whenever required by a participating country or state Inclusion criteria in LTE phase:

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Guntersville?

Yes, this clinical trial (NCT05535946) has an active research site in Guntersville, AL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

I cannot determine the primary medical condition from the provided information. The study title "ABTECT - Maintenance" and the conditions listed only mention the drug ABX464 and placebo, without specifying what medical condition is being treated. The brief summary section appears to contain only a localhost URL rather than actual clinical information. Treatment Options in Guntersville, AL

If you're searching for i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. treatment options in Guntersville, AL, this clinical trial (NCT05535946) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Guntersville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all i cannot determine the primary medical condition from the provided information. the study title "abtect - maintenance" and the conditions listed only mention the drug abx464 and placebo, without specifying what medical condition is being treated. the brief summary section appears to contain only a localhost url rather than actual clinical information. clinical trials near you to find additional studies recruiting in your area.

Ready to Join in Guntersville?

Take the first step toward participating in this groundbreaking clinical trial

Secure ยท Expert Care ยท Guntersville, AL